Recent CMMB News
- Chemomab Therapeutics to Report Third Quarter 2024 Financial Results and Provide a Business Update • GlobeNewswire Inc. • 10/30/2024 11:00:00 AM
- Chemomab Therapeutics Announces Late-Breaking Oral Presentation of CM-101 Phase 2 Results in Primary Sclerosing Cholangitis at AASLD The Liver Meeting® 2024 • GlobeNewswire Inc. • 10/15/2024 11:00:00 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 10/11/2024 08:01:11 PM
- Chemomab Therapeutics to Present at October 2024 Investor Conferences • GlobeNewswire Inc. • 10/01/2024 11:00:00 AM
- Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend] • Edgar (US Regulatory) • 09/16/2024 08:34:03 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 09/12/2024 08:56:36 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 09/09/2024 10:16:11 AM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 09/09/2024 04:15:09 AM
- Chemomab Therapeutics to Present at September 2024 Investor Conferences • GlobeNewswire Inc. • 08/28/2024 11:00:00 AM
- Form F-3 - Registration statement by foreign private issuers • Edgar (US Regulatory) • 08/23/2024 08:08:08 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 08/21/2024 11:00:21 AM
- Chemomab Therapeutics Announces Second Quarter 2024 Financial Results and Provides Corporate Update • GlobeNewswire Inc. • 08/21/2024 11:00:00 AM
- Chemomab Therapeutics to Report Second Quarter 2024 Financial Results and Provide a Business Update • GlobeNewswire Inc. • 08/12/2024 11:00:00 AM
- Chemomab Therapeutics Announces Closing of $10 Million Private Placement • GlobeNewswire Inc. • 07/30/2024 01:00:00 PM
- Chemomab Therapeutics Regains Compliance With Nasdaq Minimum Bid Price Requirement • GlobeNewswire Inc. • 07/26/2024 11:00:00 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 07/25/2024 12:09:40 PM
- Chemomab Therapeutics Announces $10 Million Private Placement • GlobeNewswire Inc. • 07/25/2024 11:38:21 AM
- Chemomab Therapeutics Announces Positive Phase 2 Trial Results: CM-101 Achieves Primary and Secondary Endpoints Demonstrating Anti-Fibrotic, Anti-Inflammatory and Anti-Cholestatic Effects in Patients with Primary Sclerosing Cholangitis • GlobeNewswire Inc. • 07/25/2024 11:00:00 AM
- Chemomab Therapeutics Announces New Publications Reinforcing the Clinical Potential of Its CCL24-Neutralizing Antibody CM-101 in Primary Sclerosing Cholangitis • GlobeNewswire Inc. • 06/18/2024 11:00:00 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 06/12/2024 08:02:17 PM
- Chemomab Therapeutics Presents Data Supporting the Clinical Potential of CM-101 as a Novel Treatment for Primary Sclerosing Cholangitis at EASL 2024 and a Gordon Research Conference • GlobeNewswire Inc. • 06/06/2024 11:00:00 AM
- Chemomab Therapeutics to Participate in Upcoming Scientific Conferences • GlobeNewswire Inc. • 05/17/2024 11:00:00 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 05/09/2024 11:00:40 AM
- Chemomab Therapeutics Announces First Quarter 2024 Financial Results and Provides Corporate Update • GlobeNewswire Inc. • 05/09/2024 11:00:00 AM
CBD Life Sciences Inc. (CBDL) Launches High-Demand Mushroom Gummy Line for Targeted Wellness Needs, Tapping into a Booming $20 Billion Market • CBDL • Oct 31, 2024 8:00 AM
Nerds On Site Announces Q1 Growth and New Initiatives for the Remainder of 2024 • NOSUF • Oct 31, 2024 7:01 AM
Innovation Beverage Group Receives Largest Shipment of its Top-Selling Bitters to Date in the U.S.-Ready to Meet Growing Demand from Expanding Distribution Network • IBG • Oct 30, 2024 12:22 PM
Element79 Gold Corp to Update Investors on the Emerging Growth Conference on October 31, 2024 • ELMGF • Oct 30, 2024 9:08 AM
CBD Life Sciences Inc. (CBDL) Announces Grand View Research Report Findings on High - Growth CBD Equine Market, Aiming to Drive Unprecedented Shareholder Value • CBDL • Oct 29, 2024 10:19 AM
Integrated Ventures Announces Partnership And Lease Agreement with Driptide Wellness - Leading Health and Wellness Provider. • INTV • Oct 29, 2024 8:45 AM